iiinova — where your digital self keeps evolving

Replies

ME/CFS Science @mecfsscience.org · 20/09/2026

1) The team of Andreas Goebel was the first to transfer autoantibodies of fibromyalgia patients to mice (similar studies later followed in Long Covid). In this paper, they tested rozanolixizumas: a drug that lowers circulating antibody levels. A brief summary of the results 👇

2189

Chris Hutchings #ChoirsForClimate @hutchingsmusic.bsky.social · 20/09/2026

Good to see non-positive results being widely reported, rather than just sweetener the carpet. Finding that something doesn't work (or in this case, doesn't work very much if at all) is nearly as important as finding what does.

020

ME/CFS Science @mecfsscience.org · 20/09/2026

2) Rozanolixizumab is a monoclonal antibody that targets the neonatal Fc receptor (FcRn). This receptor normally protects antibodies from breakdown, so blocking it leads to a reduction in antibodies. The drug is already approved as a treatment for myasthenia gravis.

180